Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF® -treated patients

Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF^® -treated patients

Haemophilia. 2016 Mar;22(2):e101-e103. doi: 10.1111/hae.12867. Epub 2016 Jan 29.

¹ Laboratory of Haematology, Haemophilia Care Centre and University Hospital of Tours, Tours, France.
² Laboratory of Haematology, Haemophilia Care Centre and University Hospital of Nantes, Nantes, France.
³ Laboratory of Haematology, Haemophilia Care Centre and University Hospital of Clamart, Clamart, France.
⁴ Laboratory of Haematology, Haemophilia Care Centre and University Hospital of Paris Necker, Paris Necker, France.
⁵ Laboratory of Haematology, Haemophilia Care Centre and University Hospital of Marseille, Marseille, France.
⁶ Laboratory of Haematology, Haemophilia Care Centre and University Hospital of Lille, Lille, France.

No abstract available